Showing results (1611-1620 of 1,920) with videos related to
Sort By:
Pageof 192
RMD Open|March 28, 2025
Trends and influences in women authorship in randomised controlled trials in rheumatology: a comprehensive analysis of all published RCTs from 2009 to 2023Kim Lauper, Diana Buitrago-Garcia, Delphine S Courvoisier, et al.RMD Open|March 23, 2025
Immunoglobulins G from Patients with Systemic Sclerosis Modify the Molecular Signatures of Endothelial CellsAurélien Chepy, Solange Vivier, Fabrice Bray, et al.RMD Open|December 3, 2015
CorrectionRMD Open|December 3, 2015
Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?Sofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.RMD Open|February 6, 2016
Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health surveyJaime C Branco, Ana M Rodrigues, Nélia Gouveia, et al.RMD Open|July 13, 2016
Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritisPhilippe Carron, Bieke Lambert, Liesbet Van Praet, et al.RMD Open|August 30, 2017
Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritisJürgen Braun, Xenofon Baraliakos, Kay-Geert Hermann, et al.RMD Open|June 24, 2016
Long-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measuresJoel M Kremer, David A Lawrence, Robert Hamilton, et al.RMD Open|May 14, 2016
Efficacy of etanercept in combination with methotrexate in moderate-to-severe rheumatoid arthritis is not dependent on methotrexate dosageG Gallo, F Brock, U Kerkmann, et al.Pageof 192